 |
 |
 |
 |
 |
 |
 |
 |
The following studies by the REACH Mass team have been published in scientific journals.
The Huang SS, Finkelstein JA, Rifas-Shiman SL, Kleinman K, Platt R. Community-level predictors of pneumococcal carriage and resistance in young children. American Journal of Epidemiology, 2004; 159(7)
Kuzujanakis M, Kleinman K, Rifas-Shiman S, Finkelstein JA. Correlates of parental antibiotic knowledge, demand, and reported use. Ambulatory Pediatrics, 2003; 3:203-210
Finkelstein JA, Huang SS, Daniel J, Rifas-Shiman, SL, Kleinman K, Goldmann D, Pelton S, DeMaria A, Platt R. Antibiotic-resistant S. pneumoniae in the PCV7 era: predictors of carriage in a multi-community sample. Pediatrics, 2003; 112(4):862-869
Finkelstein JA, Stille C, Nordin J, Davis R, Raebel MA, Roblin D, Go A, Smith D, Johnson CC, Kleinman K, Chan KA, Platt R. Reduction in antibiotic use among US children, 1996-2000. Pediatrics 2003;112:620-627
Finkelstein JA, Davis RL, Dowell SF, Metlay JP, Soumerai SB, Rifas-Shiman, SL, Higham M, Miller Z, Miroshnik I, Pedan A, Platt R. Reducing antibiotic use in children: A randomized trial in 12 practices. Pediatrics, 2001; 108(1): 1-7
Huang SS, Platt R, Rifas-Shiman S, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumoccocal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005 116:e408-e413.
Finkelstein JA, Stille CJ, Rifas-Shiman SL, Goldmann D. Watchful Waiting for Acute Otitis Media: Are Parents and Physicians Ready? Pediatrics 2005; 115:1466-1473.
Stille CJ, Andrade SE, Huang S, Nordin J, Raebel MA, Go AS, Chan KA, Finkelstein JA. Increased use of second-generation macrolide antibiotics for children in nine US health plans. Pediatrics 2004; 114:1206-1211.
